[ Price : $8.95]
Federal Register Notice: FDA releases a document for industry: Draft Guidance on Progesterone to provide recommendations on bioequ...[ Price : $8.95]
Federal Register Notice: FDA releases a draft guidance: Information to Support a Claim of Electromagnetic Compatibility (EMC) of E...[ Price : $8.95]
Federal Register Final order: FDA classifies a gastrointestinal assay into Class 2.[ Price : $8.95]
FDA accepts for priority review an Acadia Pharmaceuticals NDA for Nuplazid (pimavanserin) for treating psychosis associated with P...[ Price : $8.95]
Tryton Medical files the final module of its PMA for the Tryton Side Branch Stent, indicated for treating bifurcated lesions in pa...[ Price : $8.95]
Teva petitions FDA asking it not to approve any ANDAs that reference Treanda (bendamustine hydrochloride) until its orphan exclusi...[ Price : $8.95]
FDA posts a guidance on Human Immunodeficiency Virus-1 Infection: Developing Antiretroviral Drugs for Treatment that provides reco...[ Price : $8.95]
FDA grants Daiichi Sankyo and Plexxikon a breakthrough therapy designation for their investigational oral CSF-1R inhibitor pexidar...